Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Engineered exosome biomedical technologies for precision diagnosis and therapy in orthopedic diseases

Wu Y., Ma R., Jiang H.

Narrative Review on Osteoarthritis, Chronic Inflammation, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Med (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42058425
PMCID
PMC13120916
DOI
10.3389/fmed.2026.1788658

Abstract (original English)

With population aging and sports-related injuries on the rise, the incidence of osteoarthritis, osteoporotic fractures, nonunion bone defects, and bone tumors continues to increase, while conventional pharmacologic and surgical interventions face limitations in target specificity, safety, and cost-effectiveness. Extracellular vesicles, particularly exosomes, are cell-derived nanoscale vesicles that can be engineered via surface ligand/peptide conjugation, membrane protein engineering, and nucleic acid or protein cargo loading to improve targeting, stability, and controlled release. These advances position engineered exosomes as promising platforms for the diagnosis and treatment of orthopedic disorders. Here, we review exosome architecture and biological properties, and systematically summarize extraction, purification, and engineering strategies, alongside their applications to osteoarthritis, osteoporosis, fracture healing, and bone malignancies. Reported therapeutic mechanisms include promotion of osteogenesis and angiogenesis, immunomodulation and anti-inflammatory effects, and regulation of autophagy and apoptosis. Nevertheless, significant barriers remain for clinical translation. To enable routine clinical use, future work should address product heterogeneity, scalable manufacturing, cargo stability, release kinetics, and long-term safety, supported by robust quality con

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research